請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37117
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 呂勝春 | |
dc.contributor.author | Shang-Yun Liu | en |
dc.contributor.author | 劉尚昀 | zh_TW |
dc.date.accessioned | 2021-06-13T15:19:30Z | - |
dc.date.available | 2008-08-08 | |
dc.date.copyright | 2008-08-08 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-07-24 | |
dc.identifier.citation | 1. Wang Z, Takemori H, Halder SK, Nonaka Y, Okamoto M. (1999) Cloning of a novel kinase (SIK) of the SNF1/AMPK family from high salt diet-treated rat
adrenal. FEBS Lett. 453, 135-9. 2. Horike N, Takemori H, Katoh Y, Doi J, Min L, Asano T, Sun XJ, Yamamoto H, Kasayama S, Muraoka M, Nonaka Y, Okamoto M. (2003) Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2. J Biol Chem. 278, 18440-7. 3. Katoh Y, Takemori H, Horike N, Doi J, Muraoka M, Min L, Okamoto M. (2004) Salt-inducible kinase (SIK) isoforms: their involvement in steroidogenesis and adipogenesis. Mol Cell Endocrinol. 217, 109-12. 4. Okamoto M, Takemori H, Katoh Y. (2004) Salt-inducible kinase in steroidogenesis and adipogenesis. Trends Endocrinol Metab. 15, 21-6. 5. Feldman JD, Vician L, Crispino M, Hoe W, Baudry M, Herschman HR. (2000) The salt-inducible kinase, SIK, is induced by depolarization in brain. J Neurochem. 74, 2227-38. 6. Lin X, Takemori H, Katoh Y, Doi J, Horike N, Makino A, Nonaka Y, Okamoto M. (2001) Salt-inducible kinase is involved in the ACTH/cAMP-dependent protein kinase signaling in Y1 mouse adrenocortical tumor cells. Mol Endocrinol. 15, 1264-76. 7. Doi J, Takemori H, Lin XZ, Horike N, Katoh Y, Okamoto M. (2002) Salt-inducible kinase represses cAMP-dependent protein kinase-mediated activation of human cholesterol side chain cleavage cytochrome P450 promoter through the CREB basic leucine zipper domain. J Biol Chem. 277, 15629-37. 8. Takemori H, Katoh Y, Horike N, Doi J, Okamoto M. (2002) ACTH-induced nucleocytoplasmic translocation of salt-inducible kinase. Implication in the protein kinase A-activated gene transcription in mouse adrenocortical tumor cells. J Biol Chem. 277, 42334-43. 9. Katoh Y, Takemori H, Min L, Muraoka M, Doi J, Horike N, Okamoto M. (2004) Salt-inducible kinase-1 represses cAMP response element-binding protein activity both in the nucleus and in the cytoplasm. Eur J Biochem. 271, 4307-19. 10. Screaton RA, Conkright MD, Katoh Y, Best JL, Canettieri G, Jeffries S, Guzman E, Niessen S, Yates JR 3rd, Takemori H, Okamoto M, Montminy M. (2004) The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell. 119, 61-74. 11. Takemori H, Kajimura J, Okamoto M. (2007) TORC-SIK cascade regulates CREB activity through the basic leucine zipper domain. FEBS J. 274, 3202-9. 12. Dentin R, Liu Y, Koo SH, Hedrick S, Vargas T, Heredia J, Yates J, Montminy M. (2007) Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature. 449, 366-9. 13. Du J, Chen Q, Takemori H, Xu H. (2008) SIK2 can be activated by deprivation of nutrition and it inhibits expression of lipogenic genes in adipocytes. Obesity. 16, 531-8. 14. Ron D, Walter P. (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 8, 519-29. 15. Harding HP, Zhang Y, Ron D. (1999) Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature. 397, 271-4. 16. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, Ron D. (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science. 287, 664-6. 17. Wek RC, Jiang HY, Anthony TG. (2006) Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans. 34, 7-11. 18. Meusser B, Hirsch C, Jarosch E, Sommer T. (2005) ERAD: the long road to destruction. Nat Cell Biol. 7, 766-72. 19. Rabinovich E, Kerem A, Fröhlich KU, Diamant N, Bar-Nun S. (2002) AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol Cell Biol. 22, 626-34. 20. Ichimura T, Isobe T, Okuyama T, Takahashi N, Araki K, Kuwano R, Takahashi Y. (1988) Molecular cloning of cDNA coding for brain-specific 14-3-3 protein, a protein kinase-dependent activator of tyrosine and tryptophan hydroxylases. Proc Natl Acad Sci. 85, 7084-8. 21. Toker A, Sellers LA, Amess B, Patel Y, Harris A, Aitken A. (1992) Multiple isoforms of a protein kinase C inhibitor (KCIP-1/14-3-3) from sheep brain. Amino acid sequence of phosphorylated forms. Eur J Biochem. 206, 453-61. 22. Aitken A. (2006) 14-3-3 proteins: a historic overview. Semin Cancer Biol. 16, 162-72. 23. Mhawech P. (2005) 14-3-3 proteins--an update. Cell Res. 15, 228-36. 24. Hermeking H, Benzinger A. (2006) 14-3-3 proteins in cell cycle regulation. Semin Cancer Biol. 16, 183-92. 25. Mackintosh C. (2004) Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem J. 381, 329-42. 26. Kusakabe M, Nishida E. (2004) The polarity-inducing kinase Par-1 controls Xenopus gastrulation in cooperation with 14-3-3 and aPKC. EMBO J. 23, 4190- 4201. 27. Hurov J. B, Watkins J. L, Piwnica-Worms H. (2004) Atypical PKC phosphorylates PAR-1 kinases to regulate localization and activity. Curr Biol. 14, 736-741. 28. Al-Hakim AK, Göransson O, Deak M, Toth R, Campbell DG, Morrice NA, Prescott AR, Alessi DR. (2005) 14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK. J Cell Sci. 118, 5661-73. 29. Halawani D, Latterich M. (2006) p97: The cell's molecular purgatory? Mol Cell. 22, 713-7. 30. Meyer HH. (2005) Golgi reassembly after mitosis: the AAA family meets the ubiquitin family. Biochim Biophys Acta. 1744, 481-92. 31. Hosoi T, Hyoda K, Okuma Y, Nomura Y, Ozawa K. (2007) Akt up- and down-regulation in response to endoplasmic reticulum stress. Brain Res. 1152, 27-31. 32. Matthews JA, Belof JL, Acevedo-Duncan M, Potter RL. (2007) Glucosamine- induced increase in Akt phosphorylation corresponds to increased endoplasmic reticulum stress in astroglial cells. Mol Cell Biochem. 298, 109-23. 33. Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, Jung SY, Huang Q, Qin J, Su B. (2006) SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell. 127, 125-37. 34. Yang Q, Inoki K, Ikenoue T, Guan KL. (2006) Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev. 20, 2820-32. 35. Facchinetti V, Ouyang W, Wei H, Soto N, Lazorchak A, Gould C, Lowry C, Newton AC, Mao Y, Miao RQ, Sessa WC, Qin J, Zhang P, Su B, Jacinto E. (2008) The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J. [Epub ahead of print] 36. Ikenoue T, Inoki K, Yang Q, Zhou X, Guan KL. (2008) Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. [Epub ahead of print] 37. Klein JB, Barati MT, Wu R, Gozal D, Sachleben LR Jr, Kausar H, Trent JO, Gozal E, Rane MJ. (2005) Akt-mediated valosin-containing protein 97 phosphorylation regulates its association with ubiquitinated proteins. J Biol Chem. 280, 31870-81. 38. Vandermoere F, El Yazidi-Belkoura I, Slomianny C, Demont Y, Bidaux G, Adriaenssens E, Lemoine J, Hondermarck H. (2006) The valosin-containing protein (VCP) is a target of Akt signaling required for cell survival. J Biol Chem. 281, 14307-13. 39. Hashimoto YK, Satoh T, Okamoto M, Takemori H. (2008) Importance of auto- phosphorylation at Ser186 in the A-loop of salt inducible kinase 1 for its sustained kinase activity. J Cell Biochem. [Epub ahead of print] 40. Millward TA, Zolnierowicz S, Hemmings BA. (1999) Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci. 24, 86-91. 41. Lizcano JM, Göransson O, Toth R, Deak M, Morrice NA, Boudeau J, Hawley SA, Udd L, Mäkelä TP, Hardie DG, Alessi DR. (2004) LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 23 , 833-43. 42. Murphy N, Bonner HP, Ward MW, Murphy BM, Prehn JH, Henshall DC. (2008) Depletion of 14-3-3 zeta elicits endoplasmic reticulum stress and cell death, and increases vulnerability to kainate-induced injury in mouse hippocampal cultures. J Neurochem. [Epub ahead of print] | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37117 | - |
dc.description.abstract | 本論文主要探討蛋白質激酶B (Akt/PKB) 在調控內質網蛋白質降解路徑中所扮演之角色,以及鹽誘導激酶2 (SIK2) 相關分子性質。本實驗室近年研究成果顯示,SIK2 會促進內質網蛋白質降解。論文中實驗結果發現,Akt 會負向調控內質網蛋白質降解。藉由基因轉殖後細胞中 Akt 蛋白之顯性抑制作用,以及給予細胞Akt抑制劑處理,發現由內質網蛋白降解路徑而降解 CD3δ 蛋白速率增加,並伴隨 SIK2 激酶活性提升。活體外實驗發現,Akt 能磷酸化 SIK2 上 358 位置的絲胺酸,並伴隨 Akt 與 SIK2 一同免疫沈澱。將 SIK2 上 358 位置的絲胺酸突變為丙胺酸,SIK2 激酶活性顯著提升,細胞內 CD3δ 具更高降解效率。以上證據提供一個可能之假設: Akt 藉由磷酸化 SIK2 降低其激酶活性,達成內質網蛋白質降解路徑之負向調控。另一方面,SIK2 與 14-3-3 具交互作用,將SIK2 上的兩個絲胺酸 (358 與 587 號位置胺基酸) 個別或共同突變成丙胺酸,與 14-3-3 結合能力降低,結合後 SIK2 之激酶活性些微提昇,本論文並發現,14-3-3在活體外實驗中為 SIK2 之基質。 | zh_TW |
dc.description.abstract | The purpose of this study is to investigate the regulatory role for Akt in ER-associated degradation, and other molecular characters of SIK2. SIK2 has been demonstrated to promote ER-associated degradation (ERAD) in our lab. Here we found that Akt negatively regulates ERAD. Treatment with Akt inhibitor VIII or overexpression of dominant negative Akt resulted in the accelerated degradation rate on CD3δ, a known substrate for ERAD, and enhanced SIK2 kinase activity in 293T cells. SIK2 was phosphorylated by Akt at Ser358 in vitro, and was associated with Akt in cells. The mutated SIK2 (S358A) comprised stronger kinase activity, and faster degradation rate on CD3δ was observed in cells expressing mutated SIK2 (S358A). These results suggest that Akt negatively regulates ERAD via phosphorylating SIK2 to repress its kinase activity. In addition, we found SIK2 physically interacts with 14-3-3. Mutations of Ser358 and Ser587 to Ala resulted in the decreased association of SIK2 with 14-3-3. We also found 14-3-3 is an in vitro substrate of SIK2, and binding of 14-3-3 to SIK2 slightly enhanced its kinase activity. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T15:19:30Z (GMT). No. of bitstreams: 1 ntu-97-R95448001-1.pdf: 1398947 bytes, checksum: d3f844f904e49bd8866b9a51a538da68 (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | Master Thesis……………………………………………………………………………i
致謝...................................................................................................................................ii中文摘要………………………………………………………………………..………iii ABSTRACT…….……...……………………………………………..………………..iv CONTENTS……………………………………………………………………….……v INTRODUCTION……………………………………………………………….……. 1 MATERIALS AND METHODS…….……………………………………...…………7 Plasmids and antibodies………………………….………...…………….……….7 Site-directed mutagenesis…….……..……………………………….………...….8 Cell culture and transfection.………...……………………………………….….9 Biochemical fractionation…….……………………...…………………………...9 Immunofluorescence staining…………………………………………………...10 In vitro kinase assay……………………………………………………………...10 Protein purification and in vitro binding assay………………………………...11 RESULTS…...…………………….…………………………………………………...13 Akt negatively regulates ER-associated degradation.........................................13 SIK2 kinase activity is increased after Akt inactivation....................................14 Akt phosphorylates SIK2 at Ser358.....................................................................15 Overexpression of mutated SIK2 (S358A) facilitates ER-associated degradation.............................................................................................................16 14-3-3 associates in SIK2’s complex and directly interacts with SIK2.............16 14-3-3 binds to Ser358 and Ser587 of SIK2.........................................................17 Comparison between subcellular localizations of wild-type, and mutated forms of SIK2.........................................................................................................18 SIK2 kinase activity is slightly increased after 14-3-3 association....................18 DISCUSSION………………………………………………………………………….20 REFERENCES………………………………………………………………………..26 FIGURES.........................……………………………………………………………..33 Fig 1. Akt inactivation facilitates CD3δ degradation in 293T cells...................33 Fig 2. Overexpression of dominant negative Akt facilitates CD3δ degradation. …………………………………………………………………………………….34 Fig 3. SIK2 kinase activity is increased when Akt is inhibited or over- expression of dominant negative Akt in 293T cells.............................................35 Fig 4. cells expressing wild-type Flag-SIK2 shows the accelerated degradation rate on CD3δ after Akt inhibitor treatment........................................................36 Fig 5. Akt phosphorylates SIK2 at Ser358 in vitro..............................................38 Fig 6. Comparison between the degradation rate of CD3δ in cells expressing wild-type SIK2 or mutated SIK2 (S358A)...........................................................39 Fig 7. Comparison between the kinase activity of wild-type SIK2 and mutated SIK2 (S358A)..........................................................................................................40 Fig 8. SIK2 directly interacts with 14-3-3ε and 14-3-3ζ in vitro........................41 Fig 9. SIK2 co-localizes with 14-3-3 in 293T cells...............................................42 Fig 10. Mutations of Ser358 and Ser587 prevent SIK2 from interacting with 14-3-3.......................................................................................................................43 Fig 11. Subcellular localizations of wild-type and mutated forms of SIK2......44 Fig 12. Binding of 14-3-3 to SIK2 slightly enhances its kinase activity.……....45 Fig 13. SIK2 phosphorylates 14-3-3 in vitro........................................................46 | |
dc.language.iso | en | |
dc.title | Akt對內質網蛋白質降解路徑的調控以及SIK2之生化性質分析 | zh_TW |
dc.title | Regulation of ER-associated Degradation by Akt and Biochemical Analysis of SIK2 | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 陳瑞華,周祖述 | |
dc.subject.keyword | 內質網蛋白質降解,蛋白質激酶,B,鹽誘導激酶,2,激酶,活性,14-3-3, | zh_TW |
dc.subject.keyword | ERAD,Akt,SIK2,kinase activity,14-3-3, | en |
dc.relation.page | 46 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2008-07-24 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 分子醫學研究所 | zh_TW |
顯示於系所單位: | 分子醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf 目前未授權公開取用 | 1.37 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。